These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 16286541

  • 1. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.
    Gajdos P, Tranchant C, Clair B, Bolgert F, Eymard B, Stojkovic T, Attarian S, Chevret S, Myasthenia Gravis Clinical Study Group.
    Arch Neurol; 2005 Nov; 62(11):1689-93. PubMed ID: 16286541
    [Abstract] [Full Text] [Related]

  • 2. Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin.
    Gajdos P, Chevret S.
    Ann N Y Acad Sci; 2008 Nov; 1132():271-5. PubMed ID: 18096850
    [Abstract] [Full Text] [Related]

  • 3. IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.
    Zinman L, Bril V.
    Ann N Y Acad Sci; 2008 Nov; 1132():264-70. PubMed ID: 18567877
    [Abstract] [Full Text] [Related]

  • 4. IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial.
    Zinman L, Ng E, Bril V.
    Neurology; 2007 Mar 13; 68(11):837-41. PubMed ID: 17353471
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
    Kishiyama JL, Valacer D, Cunningham-Rundles C, Sperber K, Richmond GW, Abramson S, Glovsky M, Stiehm R, Stocks J, Rosenberg L, Shames RS, Corn B, Shearer WT, Bacot B, DiMaio M, Tonetta S, Adelman DC.
    Clin Immunol; 1999 May 13; 91(2):126-33. PubMed ID: 10227804
    [Abstract] [Full Text] [Related]

  • 6. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
    Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C.
    Ann Neurol; 1997 Jun 13; 41(6):789-96. PubMed ID: 9189040
    [Abstract] [Full Text] [Related]

  • 7. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
    Achiron A, Kishner I, Sarova-Pinhas I, Raz H, Faibel M, Stern Y, Lavie M, Gurevich M, Dolev M, Magalashvili D, Barak Y.
    Arch Neurol; 2004 Oct 13; 61(10):1515-20. PubMed ID: 15477504
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of myasthenia gravis with intravenous immunoglobulin G (IVIG)].
    Lavrnić DB, Stojanović V, Marinković Z, Pavlović S, Vidaković A, Apostolski S.
    Srp Arh Celok Lek; 1995 Oct 13; 123(5-6):146-8. PubMed ID: 17974459
    [Abstract] [Full Text] [Related]

  • 9. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, Sørensen PS, Maas-Enriquez M, Sommerauer B, Hanna K, PRIVIG Study Group, UBC MS/MRI Research Group.
    Neurology; 2008 Jul 22; 71(4):265-71. PubMed ID: 18645164
    [Abstract] [Full Text] [Related]

  • 10. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
    Pittayanon R, Treeprasertsuk S, Phanthumchinda K.
    J Med Assoc Thai; 2009 Apr 22; 92(4):478-82. PubMed ID: 19374297
    [Abstract] [Full Text] [Related]

  • 11. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
    Liu JF, Wang WX, Xue J, Zhao CB, You HZ, Lu JH, Gu Y.
    Ther Apher Dial; 2010 Apr 22; 14(2):153-60. PubMed ID: 20438536
    [Abstract] [Full Text] [Related]

  • 12. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P, Chevret S, Toyka K.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD002277. PubMed ID: 18254004
    [Abstract] [Full Text] [Related]

  • 13. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.
    Arnold DF, Burton J, Shine B, Wojnarowska F, Misbah SA.
    Br J Dermatol; 2009 May 23; 160(5):1098-102. PubMed ID: 19222460
    [Abstract] [Full Text] [Related]

  • 14. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P, Chevret S, Toyka KV.
    Cochrane Database Syst Rev; 2012 Dec 12; 12(12):CD002277. PubMed ID: 23235588
    [Abstract] [Full Text] [Related]

  • 15. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS, Goodman BP, Harper CM, Bosch PE, Hoffman-Snyder CR, Wellik KE, Wingerchuk DM, Demaerschalk BM.
    Neurologist; 2015 May 12; 19(5):145-8. PubMed ID: 25970838
    [Abstract] [Full Text] [Related]

  • 16. Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis.
    Wolfe GI, Barohn RJ, Foster BM, Jackson CE, Kissel JT, Day JW, Thornton CA, Nations SP, Bryan WW, Amato AA, Freimer ML, Parry GJ, Myasthenia Gravis-IVIG Study Group.
    Muscle Nerve; 2002 Oct 12; 26(4):549-52. PubMed ID: 12362423
    [Abstract] [Full Text] [Related]

  • 17. [Long-term treatment with 7S immunoglobulins in myasthenia gravis. Preliminary clinical results].
    Bamberg C, Janzen RW, Szabados M.
    Nervenarzt; 1996 Apr 12; 67(4):327-32. PubMed ID: 8684513
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 12; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG, Riley DS, Heger M.
    Explore (NY); 2007 Feb 12; 3(6):573-84. PubMed ID: 18005909
    [Abstract] [Full Text] [Related]

  • 20. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Latov N, Deng C, Dalakas MC, Bril V, Donofrio P, Hanna K, Hartung HP, Hughes RA, Merkies IS, van Doorn PA, IGIV-C CIDP Efficacy (ICE) Study Group.
    Arch Neurol; 2010 Jul 12; 67(7):802-7. PubMed ID: 20457948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.